000756 新華製藥
按盤價 
16.990 +0.930 (+5.791%)
16.990 +0.930 (+5.791%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.209 | 9.849 | 11.441 | 10.826 | 10.417 |
| 總資產報酬率 ROA (%) | 1.226 | 5.432 | 6.000 | 5.271 | 4.833 |
| 投入資產回報率 ROIC (%) | 1.498 | 6.693 | 7.422 | 6.631 | 6.113 | 邊際利潤分析 |
| 銷售毛利率 (%) | 18.748 | 24.114 | 29.524 | 27.154 | 27.037 |
| 營業利潤率 (%) | 5.892 | 6.312 | 6.599 | 6.354 | 6.488 |
| 息稅前利潤/營業總收入 (%) | 6.038 | 6.447 | 6.778 | 6.715 | 7.228 |
| 淨利潤/營業總收入 (%) | 4.759 | 5.749 | 6.248 | 5.679 | 5.519 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.993 | 98.566 | 106.994 | 102.275 | 91.717 |
| 價值變動淨收益/利潤總額(%) | -0.533 | 1.843 | 1.799 | 1.773 | 1.903 |
| 營業外收支淨額/利潤總額(%) | -0.338 | -0.134 | -0.356 | -1.045 | -1.034 | 償債能力分析 |
| 流動比率 (X) | 1.236 | 1.333 | 1.333 | 1.094 | 1.101 |
| 速動比率 (X) | 0.872 | 0.878 | 0.805 | 0.711 | 0.690 |
| 資產負債率 (%) | 41.855 | 42.154 | 42.365 | 47.372 | 50.203 |
| 帶息債務/全部投入資本 (%) | 29.073 | 28.887 | 28.633 | 35.112 | 24.727 |
| 股東權益/帶息債務 (%) | 232.814 | 235.109 | 237.510 | 175.807 | 245.469 |
| 股東權益/負債合計 (%) | 132.877 | 131.285 | 129.703 | 105.390 | 94.215 |
| 利息保障倍數 (X) | 36.361 | 44.956 | 33.578 | 15.734 | 8.962 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 38.309 | 33.339 | 32.466 | 34.062 | 28.494 |
| 存貨周轉天數 (天) | 55.871 | 72.446 | 79.608 | 73.754 | 80.926 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 11/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
